Detalles de la búsqueda
1.
Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis.
Br J Haematol
; 184(4): 558-569, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30506764
2.
Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial.
Pharm Res
; 36(7): 93, 2019 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31044267
3.
Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials.
Haematologica
; 102(10): 1796-1805, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28751558
4.
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study.
Lancet Oncol
; 17(2): 200-211, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26655421
5.
The HELIOS trial protocol: a phase III study of ibrutinib in combination with bendamustine and rituximab in relapsed/refractory chronic lymphocytic leukemia.
Future Oncol
; 11(1): 51-9, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-24901734
6.
Primary thrombocytosis in children.
Haematologica
; 99(4): 620-8, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24688110
7.
Real-world treatment and outcomes among older adults with chronic lymphocytic leukemia before the novel agents era.
Haematologica
; 103(10): e462-e465, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29700170
8.
Safety and immunogenicity of the tetravalent protein-conjugated meningococcal vaccine (MCV4) in recipients of related and unrelated allogeneic hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant
; 18(1): 145-9, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21820392
9.
The thrombopoietin mimetic JNJ-26366821 increases megakaryopoiesis without affecting malignant myeloid proliferation.
Leuk Lymphoma
; 61(10): 2453-2465, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32578476
10.
Real-world analysis of treatment patterns and clinical outcomes in patients with newly diagnosed chronic lymphocytic leukemia from seven Latin American countries.
Hematology
; 25(1): 366-371, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33095117
11.
Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia.
Clin Lymphoma Myeloma Leuk
; 19(11): 715-722.e6, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31447270
12.
Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS study.
Leuk Lymphoma
; 59(9): 2075-2084, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29295653
Resultados
1 -
12
de 12
1
Próxima >
>>